The North America Vendor Neutral Archive (VNA) & PACS Market is expected to witness market growth of 8.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of USD2.22 billion by 2031. The Canada market is experiencing a CAGR of 10.7% during 2024-2031. Additionally, the Mexico market would exhibit a CAGR of 10% during 2024-2031.
Vendor neutral archive (VNA) and picture archiving and communication system (PACS) systems facilitate seamless imaging data sharing across different healthcare facility departments. This capability allows for integrated care where specialists from radiology, oncology, cardiology, and other departments can collaborate efficiently using a unified imaging data set. It promotes coordinated patient care by ensuring all healthcare providers can access the most current and comprehensive imaging information.
VNA systems support the creation of longitudinal imaging records, which track a patient's imaging history over time. This feature is particularly valuable for managing chronic conditions and long-term treatments, as it provides a comprehensive view of disease progression or treatment response. It helps monitor changes, assess the effectiveness of interventions, and make informed decisions based on historical imaging data.
As cancer cases rise in Mexico, there will be a greater need for diagnostic imaging services. This increase in demand will drive the adoption of advanced PACS and VNA systems to manage, store, and access high volumes of imaging data efficiently. As per the All. Can, cancer is the third leading cause of death in Mexico. Over 195,000 new cases were registered in 2020. Breast (29.929), prostate (26.742), thyroid (11,227), colon (11,191), and cervical cancer (9,439) were among those with the highest prevalence. With the rise in CVD cases, imaging procedures such as echocardiograms, CT scans, and MRIs will be used more frequently to diagnose and manage these conditions.
This will drive demand for VNA and PACS systems capable of efficiently handling large volumes of imaging data. According to the American Heart Association, cardiovascular disease (CVD) remains the leading cause of death in the United States, accounting for 928,741 deaths in 2020. In conclusion, high rates of cancer cases and the increasing burden of CVDs in the region are driving the growth of the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model.
The US market dominated the North America Vendor Neutral Archive (VNA) & PACS Market by Country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of USD2.22 billion by 2031. The Canada market is experiencing a CAGR of 10.7% during 2024-2031. Additionally, the Mexico market would exhibit a CAGR of 10% during 2024-2031.
Vendor neutral archive (VNA) and picture archiving and communication system (PACS) systems facilitate seamless imaging data sharing across different healthcare facility departments. This capability allows for integrated care where specialists from radiology, oncology, cardiology, and other departments can collaborate efficiently using a unified imaging data set. It promotes coordinated patient care by ensuring all healthcare providers can access the most current and comprehensive imaging information.
VNA systems support the creation of longitudinal imaging records, which track a patient's imaging history over time. This feature is particularly valuable for managing chronic conditions and long-term treatments, as it provides a comprehensive view of disease progression or treatment response. It helps monitor changes, assess the effectiveness of interventions, and make informed decisions based on historical imaging data.
As cancer cases rise in Mexico, there will be a greater need for diagnostic imaging services. This increase in demand will drive the adoption of advanced PACS and VNA systems to manage, store, and access high volumes of imaging data efficiently. As per the All. Can, cancer is the third leading cause of death in Mexico. Over 195,000 new cases were registered in 2020. Breast (29.929), prostate (26.742), thyroid (11,227), colon (11,191), and cervical cancer (9,439) were among those with the highest prevalence. With the rise in CVD cases, imaging procedures such as echocardiograms, CT scans, and MRIs will be used more frequently to diagnose and manage these conditions.
This will drive demand for VNA and PACS systems capable of efficiently handling large volumes of imaging data. According to the American Heart Association, cardiovascular disease (CVD) remains the leading cause of death in the United States, accounting for 928,741 deaths in 2020. In conclusion, high rates of cancer cases and the increasing burden of CVDs in the region are driving the growth of the market.
Based on Product Type, the market is segmented into VNA (Multi-Department VNA, Department VNA, and Multi-Site VNA) and PACS (Multi-Department PACS, Department PACS, and Multi-Site PACS). Based on Vendor Type, the market is segmented into Independent Vendor and Third-party Vendor. Based on Deployment, the market is segmented into On-Premise, Cloud-Based, and Hybrid Model.
List of Key Companies Profiled
- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
Market Report Segmentation
By Product Type
- VNA
- Multi-Department VNA
- Department VNA
- Multi-Site VNA
- PACS
- Multi-Department PACS
- Department PACS
- Multi-Site PACS
By Vendor Type
- Independent Vendor
- Third-party Vendor
By Deployment
- On-Premise
- Cloud-Based
- Hybrid Model
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Others
By Application
- Cardiology
- Orthopedic
- Oncology
- Neurology
- Obstetrics & Gynecology
- Others
By Modality
- Computed Tomography
- Mammography
- MRI
- Ultrasound
- X-Rays
- PET
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
Chapter 6. North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
Chapter 7. North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
Chapter 8. North America Vendor Neutral Archive (VNA) & PACS Market by End User
Chapter 9. North America Vendor Neutral Archive (VNA) & PACS Market by Application
Chapter 10. North America Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 11. North America Vendor Neutral Archive (VNA) & PACS Market by Country
Chapter 12. Company Profiles
Companies Mentioned
Some of the key companies in the North America Vendor Neutral Archive (VNA) & PACS Market include:- Hyland Software, Inc.
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- Fujifilm Holdings Corporation
- IBM Corporation
- Carestream Health, Inc. (Onex Corporation)
- Novarad Enterprise Healthcare Solutions
- Canon, Inc. (Canon Medical Systems Corporation)
- INFINITT Healthcare Co. Ltd.
Methodology
LOADING...
